Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: SAD Study in Patients With Parkinson's Disease and Motor Fluctuations [Phase 1]

View source ↗

Summary

A Phase 1 single-ascending-dose study in people with Parkinson's disease and motor fluctuations is currently recruiting, sponsored by Serina Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Serina Therapeutics | Conditions: PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease | Phase 1 | Status: RECRUITING